8625074

Source:http://linkedlifedata.com/resource/pubmed/id/8625074

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0015133, umls-concept:C0030705, umls-concept:C0205179, umls-concept:C0282460, umls-concept:C0442027
pubmed:issue	12
pubmed:dateCreated	1996-6-26
pubmed:abstractText	The objective of this study was to define the activity and toxicity of etoposide for patients with previously treated metastatic breast cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0008-543X
pubmed:author	pubmed-author:AtienzaD MDM, pubmed-author:SwainS MSM, pubmed-author:TrochMM, pubmed-author:VogelC LCL
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	76
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2485-90
pubmed:dateRevised	2010-3-24
pubmed:meshHeading	pubmed-meshheading:8625074-Administration, Oral, pubmed-meshheading:8625074-Adult, pubmed-meshheading:8625074-Aged, pubmed-meshheading:8625074-Antineoplastic Agents, Phytogenic, pubmed-meshheading:8625074-Breast Neoplasms, pubmed-meshheading:8625074-Disease Progression, pubmed-meshheading:8625074-Etoposide, pubmed-meshheading:8625074-Female, pubmed-meshheading:8625074-Humans, pubmed-meshheading:8625074-Middle Aged, pubmed-meshheading:8625074-Treatment Outcome
pubmed:year	1995
pubmed:articleTitle	Phase II study of oral etoposide for patients with advanced breast cancer.
pubmed:affiliation	Department of Medicine, VA Medical Center, Amarillo, Texas 79106, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Review, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II